The Acute Myeloid Leukemia market was valued at USD 2,500.00 Million in 2022 and is expected to reach USD 5,866.25 Million by 2030, growing at a CAGR of 11.3% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.